News

The Centers for Medicare & Medicaid Services has posted a FAQ on the Coronavirus Aid, Relief, and Economic Security Act requirement that providers of COVID-19 diagnostic tests make public the cash price for the tests on their website during the public health emergency.

The nonprofit hospital and health care sector will continue to face credit risks from the coronavirus into 2021, according to a report released by Moody’s Investors Service.

The Coalition to Protect America's Health Care, of which the AHA is a founding member, is urging 2.2 million members to ask their lawmakers to include support for hospitals and health systems in the next COVID-19 relief proposal.

President Trump announced plans to expand and restructure the Strategic National Stockpile.

The AHA, joined by America’s Essential Hospitals, Association of American Medical Colleges, and Federation of American Hospitals urged the Supreme Court to reverse a federal appeals court decision that held the Affordable Care Act's individual mandate unconstitutional.

China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines, treatments and testing from networks and personnel affiliated with COVID-19-related research, which could jeopardize the delivery of secure, effective and efficient treatment options, the FBI and CISA warned.

This week of thanks acknowledges the tremendous effort front-line caregivers are putting forth each day to treat and protect Americans during COVID-19.

The Food and Drug Administration authorized the emergency use of the Ascom telecare IP Nurse Call System and Eko electrocardiogram Low Ejection Fraction Tool.

Community-based primary and behavioral health care providers, hospital emergency departments and other eligible entities can apply through May 22 for grants of up to $800,000 to support suicide prevention during the COVID-19 pandemic, the Substance Abuse and Mental Health Services Administration announced.

The Internal Revenue Service today issued guidance that, among other changes, expands the ability of taxpayers to make mid-year elections for health coverage, health flexible spending arrangements and dependent care assistance programs in response to changing needs due to the COVID-19 pandemic.

The Small Business Administration provided further clarity on how it reviews borrowers’ required good-faith certification for Paycheck Protection Program loan requests.

FEMA updated its policy for determining medical care costs eligible for assistance under its Public Assistance Program, available to government entities and certain private non-profit organizations during the COVID-19 emergency. 

Recognizing the ongoing efforts of hospital and health systems fighting COVID-19 in their communities while also providing care for other patient needs, the AHA has cancelled its Leadership Summit, scheduled for July 19-21, 2020 in San Diego, and all affiliated events.

CMS next month will begin collecting and distributing risk adjustment payments in the permanent risk adjustment program for benefit years 2014-2018, the agency announced yesterday.

The Centers for Medicare & Medicaid Services May 12 and May 14 will host calls for hospitals, health systems and providers on COVID-19.

Deaths were 75% higher than usual in New York City between March 11 and May 2, with most of the estimated 24,172 increase likely due to COVID-19, according to a report by the New York City Department of Health and Mental Hygiene released by the CDC.

A new AHA resource shares ways hospitals and health systems are caring for mothers and babies during the COVID-19 crisis.

The FDA authorized the emergency use of Fresenius Propoven 2% Emulsion, which the agency says "may be effective to maintain sedation via continuous infusion in patients greater than 16 years old with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting."

The Centers for Medicare & Medicaid Services recently provided hospitals with new Medicare blanket waivers to address the COVID-19 public health emergency.

The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said at a Senate Health, Education, Labor and Pensions Committee hearing.